Shopping Cart
- Remove All
- Your shopping cart is currently empty
TAK-218 is a candidate compound designed for use in treating central nervous system injuries and ischemia. It demonstrates significant radical scavenging activity and antioxidant properties. Additionally, TAK-218 inhibits the release of dopamine.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | TAK-218 is a candidate compound designed for use in treating central nervous system injuries and ischemia. It demonstrates significant radical scavenging activity and antioxidant properties. Additionally, TAK-218 inhibits the release of dopamine. |
Molecular Weight | 437.45 |
Formula | C24H34Cl2N2O |
Cas No. | 156756-10-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.